Dynamic regulation of serum aryl hydrocarbon receptor agonists in MS
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received February 1, 2017
- Accepted in final form March 23, 2017
- First Published June 16, 2017.
Author Disclosures
- Veit Rothhammer, MD,
- Davis M. Borucki, BSc, BA,
- Maria Isabel Garcia Sanchez, MD,
- Maria Antonietta Mazzola, MD,
- Christopher C. Hemond, MD,
- Keren Regev, MD,
- Anu Paul, PhD,
- Pia Kivisäkk, MD, PhD,
- Rohit Bakshi, MD,
- Guillermo Izquierdo, MD,
- Howard L. Weiner, MD and
- Francisco J. Quintana, PhD
- Veit Rothhammer, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Davis M. Borucki, BSc, BA,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Maria Isabel Garcia Sanchez, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Maria Antonietta Mazzola, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Christopher C. Hemond, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
American Academy of Neurology
NONE
NONE
NONE
NONE
NONE
NONE
- Keren Regev, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Anu Paul, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Pia Kivisäkk, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Research support from EMD Serono, Sanofi Genzyme, andVerily Life Sciences.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Rohit Bakshi, MD,
NONE
NONE
NONE
Dr. Bakshi serves as Editor-in-Chief of the Journal of Neuroimaging
NONE
NONE
NONE
(1) EMD Serono (2) Genentech (3) Sanofi-Genzyme (4)Novartis
NONE
NONE
NONE
(1) Biogen (2) EMD-Serono (3) Novartis (4)Sanofi-Genzyme
NONE
NONE
NONE
NONE
NONE
NONE
Dr. Bakshi's spouse holds stock in Biogen, Inc.
Dr. Bakshi's spouse holds stock in Biogen, Inc.
NONE
- Guillermo Izquierdo, MD,
Biogen-Idec, Bayer, Sanofi,Roche, Novartis, Genzyme, Almirall, Merck Serono and Teva.
NONE
NONE
NONE
NONE
NONE
NONE
Sanofi, Merck, Novartis.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Howard L. Weiner, MD and
served on the advisory board for The Guthy Jackson Charitable Foundation, Teva Pharmaceutical Industries Ltd., Biogen Idec, Novartis, Sanofi-aventis
NONE
NONE
NONE
NONE
NONE
NONE
Therapix Biogen Novartis Serono Teva Sanofi
NONE
NONE
NONE
EMD Serono
NIH
NONE
National Multiple Sclerosis Society
NONE
NONE
NONE
NONE
NONE
NONE
- Francisco J. Quintana, PhD
TEVA scientific advisory board
NONE
NONE
2012 Editorial Board Member Systems Biomedicine 2012 Editorial Board Member Inmunologia (Spain) 2013- Associate Editor Immunology (UK) 2013- Senior Editorial Board Member American Journal of Clinical and Experimental Immunology 2014- Advisory Board Member Seminars in Immunopathology
NONE
NONE
NONE
Teva, Blueprint Medicines, AnTolRx
NONE
NONE
NONE
1. EMD-Serono 2. Sanofi 3. Novartis 4. Teva 5. ONO
(1) NIH, R00 AI075285-01A2, Role PI, 2010-2012, (2) NIH, R01 AI093903-01, Role PI, 2011?2016, (3) NIH, K99AI075285-01A2, Role PI, 2009-2010
(1) Harvard Medical School, Diversity and Community Partnership Faculty Fellowship, Role PI, 2010-2012, (2) BADERC, Pilot and Feasibility Award (Quintana), Role PI, 2010-2012
(1) NMSS, RG4111A1/1, Role PI, 2009-2012, (2) NMSS, RG4048A11, Role Research Associate, 2008-2011
AnTolRx
NONE
NONE
NONE
NONE
NONE
- From the Ann Romney Center for Neurologic Diseases (V.R., D.M.B., M.A.M., C.C.H., K.R., A.P., P.K., R.B., H.L.W., F.J.Q.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Molecular Biology Service and MS Unit (M.I.G.S., G.I.), University of Seville, Spain; and Broad Institute of MIT and Harvard (F.J.Q.), Cambridge, MA.
- Correspondence to Dr. Quintana: fquintana{at}rics.bwh.harvard.edu
Article usage
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
The Aryl Hydrocarbon Receptor–Dependent TGF-α/VEGF-B Ratio Correlates With Disease Subtype and Prognosis in Multiple SclerosisAna Cirac, Thanos Tsaktanis, Tobias Beyer et al.Neurology: Neuroimmunology & Neuroinflammation, July 23, 2021 -
Article
Aryl Hydrocarbon Receptor Plasma Agonist Activity Correlates With Disease Activity in Progressive MSThanos Tsaktanis, Tobias Beyer, Lucy Nirschl et al.Neurology: Neuroimmunology & Neuroinflammation, December 24, 2020 -
Editorial
Aryl hydrocarbon receptor activity may serve as a surrogate marker for MS disease activityJoseph J. Sabatino, Jr, Scott S. Zamvil et al.Neurology: Neuroimmunology & Neuroinflammation, June 16, 2017 -
Editor's Corner
The case for autoimmune neurologyJosep Dalmau et al.Neurology: Neuroimmunology & Neuroinflammation, July 06, 2017